Boswellia serrata, Apium graveolens, Zingiber officinale, and Curcuma longa supplementation in shoulder tendinitis

The effect of the Boswellia serrata, Apium graveolens, Zingiber officinale, and Curcuma longa supplementation on pain intensity, physical function, and shoulder joint range of motion in patients shoulder tendinitis: A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161022030424N7

Enrollment

Registered

2023-03-08

Start date

2023-04-04

Completion date

Unknown

Last updated

2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder tendinitis. Bicipital tendinitis, unspecified shoulder

Interventions

Intervention 1: Intervention group 1: Arthrodin herbal tablet (containing a concentrated extract equivalent to 1900 mg of Boswellia serrata oleoresin (condor), an extract equivalent to 1000 mg of Apiu

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Recent shoulder pain for at least three months Pain in the proximal lateral part of the arm (dermatome C5) which is exacerbated by abduction No restrictions in the shoulder passive range of motion suggesting adhesive capsulitis Pain on Full Can Test and/or Resisted External Rotation Test Positive Hawkins-Kennedy test or Neer's test Shoulder radiography with no evidence of fracture or bone disorders

Exclusion criteria

Exclusion criteria: Pain due to severe radiculopathy in the neck Corticosteroid injection in the last six months People taking antidepressants, antiplatelet drugs, low molecular weight heparin, and thrombolytic agents.

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: Pain intensity measurement at baseline (before intervention) and 8 weeks after intervention. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Shoulder physical function. Timepoint: Shoulder physical function measurement at baseline (before intervention) and 8 weeks after intervention. Method of measurement: Shoulder Pain and Disability Index (SPADI).;Shoulder range of motion. Timepoint: Shoulder range of motion measurement at baseline (before intervention) and 8 weeks after intervention. Method of measurement: Metal goniometer.;Inflammatory indices. Timepoint: Inflammatory indices measurement at baseline (before intervention) and 8 weeks after intervention. Method of measurement: Biochemical methods.;Oxidative stress indices. Timepoint: Oxidative stress indices measurement at baseline (before intervention) and 8 weeks after intervention. Method of measurement: Biochemical methods.	—

Measure

Time frame

Shoulder physical function. Timepoint: Shoulder physical function measurement at baseline (before intervention) and 8 weeks after intervention. Method of measurement: Shoulder Pain and Disability Index (SPADI).;Shoulder range of motion. Timepoint: Shoulder range of motion measurement at baseline (before intervention) and 8 weeks after intervention. Method of measurement: Metal goniometer.;Inflammatory indices. Timepoint: Inflammatory indices measurement at baseline (before intervention) and 8 weeks after intervention. Method of measurement: Biochemical methods.;Oxidative stress indices. Timepoint: Oxidative stress indices measurement at baseline (before intervention) and 8 weeks after intervention. Method of measurement: Biochemical methods.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Rahbar

Tabriz University of Medical Sciences

rahbar63@gmail.com+98 41 3336 1928

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026